Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Evogene Ltd. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 28 | 14 | −14 |
| SharesConverted for a 1-for-10 split | 392.7K | 552.5K | +159.8K (+40.7%) |
| Value | $2.55M | $1.70M | −$856.9K (−33.6%) |
New holders (3)
Institutions that held Evogene Ltd. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 194,692 | $597.7K | 0.02% |
| Renaissance Investment Group LLC | 10,000 | $30.7K | 0.01% |
| Tower Research Capital LLC (TRC) | 290 | $890 | 0.00% |
Sold out (17)
Institutions that held Evogene Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| LPL Financial LLC | 67,335 | $43.8K |
| Susquehanna International Group, LLP | 61,351 | $39.9K |
| Geode Capital Management, LLC | 59,007 | $38.4K |
| Renaissance Technologies LLC | 44,700 | $29.1K |
| Joel Isaacson & Co., LLC | 30,300 | $19.7K |
| Citadel Advisors LLC | 23,710 | $15.4K |
| Sigma Planning Corp | 22,775 | $14.8K |
| Csenge Advisory Group | 20,762 | $13.5K |
| XTX Topco Ltd | 15,205 | $9.89K |
| Private Advisor Group, LLC | 14,013 | $9.12K |
| Susquehanna International Group Ltd. | 13,321 | $8.66K |
| Two Sigma Securities, LLC | 13,145 | $8.55K |
| Cypress Capital, LLC | 400 | $260 |
| Qube Research & Technologies Ltd | 50 | $33 |
| Coppell Advisory Solutions LLC | 27 | $18 |
| Simplex Trading, LLC | 1,168 | $0 |
| Toronto Dominion Bank | 20 | – |